RxDoctor Payments Data

Kathleen Hinderlinder, PA

Physician Assistant · Baltimore, MDNPI 1194159277

Payments from drug & device makers

$390in general payments, 2019–2025

Across 23 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$165
  • Amneal Pharmaceuticals LLC$70
  • AbbVie$30
  • Sumitomo Pharma America, Inc.$29
  • Eisai Inc.$25
  • UCB, Inc.$22
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$390 in reported general payments places this provider in the 65th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$6,255
Medicare patients
42
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AptiomEslicarbazepine Acetate74$177,916
XcopriCenobamate106$153,112
BriviactBrivaracetam71$140,901
RytaryCarbidopa/Levodopa47$74,937
FycompaPerampanel43$60,966
Tetrabenazine20$60,444
Lacosamide295$52,964
EpidiolexCannabidiol (Cbd)15$48,885
Levetiracetam382$15,836
Oxcarbazepine114$9,036
NayzilamMidazolam13$8,449
Clobazam76$7,947
Carbamazepine ErCarbamazepine37$6,199
Lamotrigine167$5,373
DilantinPhenytoin Sodium Extended11$5,340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sunovion Pharmaceuticals Inc.Aptiom$165$177,91674 claims
UCB, Inc.Briviact, Nayzilam$22$149,35084 claims
Amneal Pharmaceuticals LLCRytary$70$74,93747 claims
Eisai Inc.Fycompa$25$60,96643 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →